Amyloidosis, Immunoglobulin Light-chain clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, accepting new patients by invitation only
This registry is a observational, multi-center study designed to collect data and analyze it retrospectively on patients with cardiac amyloidosis who have been evaluated and treated at major amyloid centers across the US and internationally between 1997 and 2025.
San Francisco, California and other locations